company logo

Senior Director, Health Economics and Outcomes Research (HEOR) at Novavax, Inc in Gaithersburg, MD



$200K — $250K *


Healthcare Management


11 - 15 years

Job Description

See More

Valid through: 11/2/2020

About Novavax, Inc.

Novavax, Inc. is a clinical-stage vaccine company headquartered in Gaithersburg, Maryland with additional facilities in Rockville, Maryland and Uppsala, Sweden. Novavax is a public company that trades under the symbol "NVAX". In June 2013, Novavax acquired the Matrix-MTM adjuvant platform with the purchase of Swedish company Isconova AB. Novavax is developing a vaccine candidate for respiratory syncytial virus (RSV), which is being studied in older adults, infants via maternal immunization and pediatrics. There are currently no vaccines approved for RSV. Novavax announced positive top-line data from a Phase 2 clinical trial of its RSV-F vaccine in older adults. A Phase 3 clinical trial of the RSV-F vaccine for older adults was initiated in November 2015. In September 2016, Novavax announced that its RSV-F vaccine for lower respiratory tract disease did not meet its objectives in a clinical trial. The vaccine was well-tolerated by patients. But it did not demonstrate efficacy in preventing RSV-associated lower respiratory tract disease or reducing the occurrence of all symptomatic respiratory disease, according to a company statement. Companys stock collapsed more than 85% after the announcement.
stats icon
Total Jobs:
stats icon
Average Pay:
stats icon
Total value of jobs:
stats icon
% Masters:
Learn More About Novavax, Inc. view all icon
* Ladders Estimates

More Jobs at Novavax, Inc.

Similar Jobs

Director, HEOR

$200K — $250K

9 days ago

More Pharmaceuticals & Biotech Jobs

Principal Electrical Engineer (Medical Device)

$150K — $160K

Confidential Company

Cambridge, MA 02138


Toxicology Manager

Confidential Company

Greensboro, NC 27401

2 days ago

Find similar Research Scientist jobs: